BioSpace News Archive

Genetown

Intellia Establishes Proof-of-Concept for in vivo CRISPR Bone Marrow Editing

Intellia Therapeutics presented preclinical data of its non-viral genome editing platform at the Keystone eSymposium: Precision Engineering of the Genome, Epigenome and Transcriptome.

March 11, 2021
·
3 min read
·
Mark Terry
Drug Development

COVID-19 Wins and Losses: Genentech’s Actemra Flunks Trial; Vir & GSK’s Antibody Dazzles

Genentech reported its rheumatoid arthritis drug Actemra failed to hit its primary endpoint in a COVID-19 trial, while Vir and GlaxoSmithKline’s antibody against COVID-19 demonstrated 85% efficacy.

March 11, 2021
·
3 min read
·
Mark Terry
Drug Development

COVID-19 Vaccine News: Moderna Variant Vaccine Begins Human Testing, AZ Put on Hold in Denmark

Patients in a Phase II trial have begun receiving Moderna’s vaccine against the SARS-CoV-2 variant first identified in South Africa, the company announced.

March 11, 2021
·
2 min read
·
Mark Zipkin
BioMidwest

Research Roundup: AI Helps ID Alzheimer’s Treatments and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

March 11, 2021
·
6 min read
·
Mark Terry
How to Use Public Relations to Improve your Recruitment Strategy

Using public relations strategies creates more opportunities for passive candidates to be exposed to your organization – and learn about your open roles.

March 11, 2021
·
3 min read
·
Chantal Dresner
Business

COVID-19 One Year Mark – Losses Far Greater than Imagined

It has been one year since COVID-19 was declared a global pandemic. In that time, more than 118 million people have contracted the virus and 2,622,190 people, including 529,267 in the United States, have died as a result.

March 11, 2021
·
2 min read
·
Alex Keown
Business

BioSpace Movers & Shakers, March 12

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

March 11, 2021
·
7 min read
·
Alex Keown
FDA

AVEO’s Cancer Drug Finally Approved in US, 3.5 Years After EU Approval

The U.S. FDA approved AVEO Oncology’s Fotivda (tivozanib) for adults with relapsed or refractory advanced renal cell carcinoma (RCC) in people who have had two or more previous systemic therapies.

March 11, 2021
·
2 min read
·
Mark Terry
Takeda Takes on the World with Big Growth Plans for the Decade

The Japanese pharma giant is aiming for double-digit revenue growth of its Growth and Emerging Markets Business Unit (GEM BU) by 2030. Here’s how they plan to do it.

March 11, 2021
·
2 min read
·
Kate Goodwin
Drug Development

Hospitalized COVID-19 Death Risk Dropped by 92% With NSAA Drug Proxalutamide

Topline results from a trial in Brazil show that treatment with Kintor’s proxalutamide cut mortality risk by 92% and significantly shortened the median length of hospital stay by nine days compared with standard of care in hospitalized patients with COVID-19.

March 11, 2021
·
3 min read
·
Brandon May